Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Pas de Trois of Vitamin D, FGF23, and PTH.

Literature DB >> 27807212

The Pas de Trois of Vitamin D, FGF23, and PTH.

Tally Naveh-Many¹, Justin Silver².

Abstract

Entities: Chemical Gene

Keywords: 1,25(OH)2vitamin D; FGF23; PTH

Mesh：

Substances：

Year: 2016 PMID： 27807212 PMCID： PMC5280031 DOI： 10.1681/ASN.2016090944

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

× No keyword cloud information.

18 in total

1. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.

Authors: Vardit Lavi-Moshayoff; Gilad Wasserman; Tomer Meir; Justin Silver; Tally Naveh-Many
Journal: Am J Physiol Renal Physiol Date: 2010-08-04

2. Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.

Authors: Yi Fan; Ruiye Bi; Michael J Densmore; Tadatoshi Sato; Tatsuya Kobayashi; Quan Yuan; Xuedong Zhou; Reinhold G Erben; Beate Lanske
Journal: FASEB J Date: 2015-10-01 Impact factor: 5.191

3. Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.

Authors: Loan Nguyen-Yamamoto; Andrew C Karaplis; Rene St-Arnaud; David Goltzman
Journal: J Am Soc Nephrol Date: 2016-08-17 Impact factor: 10.121

4. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells.

Authors: M M Hurley; S Tetradis; Y F Huang; J Hock; B E Kream; L G Raisz; M G Sabbieti
Journal: J Bone Miner Res Date: 1999-05 Impact factor: 6.741

5. The parathyroid is a target organ for FGF23 in rats.

Authors: Iddo Z Ben-Dov; Hillel Galitzer; Vardit Lavi-Moshayoff; Regina Goetz; Makoto Kuro-o; Moosa Mohammadi; Roy Sirkis; Tally Naveh-Many; Justin Silver
Journal: J Clin Invest Date: 2007-12 Impact factor: 14.808

6. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.

Authors: H Galitzer; I Z Ben-Dov; Justin Silver; Tally Naveh-Many
Journal: Kidney Int Date: 2009-12-16 Impact factor: 10.612

7. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.

Authors: Tetsuhiko Sato; Yoshihiro Tominaga; Tsuneo Ueki; Norihiko Goto; Susumu Matsuoka; Akio Katayama; Toshihito Haba; Kazuharu Uchida; Shohei Nakanishi; Junichiro James Kazama; Fumitake Gejyo; Takeyoshi Yamashita; Masafumi Fukagawa
Journal: Am J Kidney Dis Date: 2004-09 Impact factor: 8.860

Review 8. FGF-23 and secondary hyperparathyroidism in chronic kidney disease.

Authors: Justin Silver; Tally Naveh-Many
Journal: Nat Rev Nephrol Date: 2013-07-23 Impact factor: 28.314

9. 25 hydroxy-vitamin D(3)-1alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone.

Authors: Dalia Somjen; Sara Katzburg; Naftali Stern; Fortune Kohen; Orly Sharon; Rona Limor; Niva Jaccard; David Hendel; Yosef Weisman
Journal: J Steroid Biochem Mol Biol Date: 2007-06-27 Impact factor: 4.292

10. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.

Authors: Yumie Rhee; Nicoletta Bivi; Emily Farrow; Virginia Lezcano; Lilian I Plotkin; Kenneth E White; Teresita Bellido
Journal: Bone Date: 2011-06-25 Impact factor: 4.398

6 in total

The Pas de Trois of Vitamin D, FGF23, and PTH.

1. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.

2. Parathyroid hormone 1 receptor is essential to induce FGF23 production and maintain systemic mineral ion homeostasis.

3. Fibroblast Growth Factor 23 Regulation by Systemic and Local Osteoblast-Synthesized 1,25-Dihydroxyvitamin D.

4. Parathyroid hormone regulates the expression of fibroblast growth factor-2 mRNA and fibroblast growth factor receptor mRNA in osteoblastic cells.

5. The parathyroid is a target organ for FGF23 in rats.

6. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.

7. Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism.

Review 8. FGF-23 and secondary hyperparathyroidism in chronic kidney disease.

9. 25 hydroxy-vitamin D(3)-1alpha hydroxylase expression and activity in cultured human osteoblasts and their modulation by parathyroid hormone, estrogenic compounds and dihydrotestosterone.

10. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.

Review 1. Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder.

Review 2. Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease.

3. Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease.

Review 4. The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia.

Review 5. Molecular Mechanisms of Parathyroid Disorders in Chronic Kidney Disease.

6. State-of-the-Art Management of Hyperphosphatemia in Patients With CKD: An NKF-KDOQI Controversies Perspective.